blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1858901

EP1858901 - BENZOTHIAZOLE, THIAZOLOPYRIDINE, BENZOOXAZOLE AND OXAZOLOPYRIDINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.09.2009
Database last updated on 12.07.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2008/45]
Former [2007/48]For all designated states
F. HOFFMANN-LA ROCHE AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / BINGGELI, Alfred
Im Kugelfang 50
CH-4102 Binningen / CH
02 / CHRIST, Andreas, Dominik
Lettenweg 8
CH-4144 Arlesheim / CH
03 / GREEN, Luke, Gideon, Granville
Oetlingerstrasse 52
CH-4057 Basel / CH
04 / GUBA, Wolfgang
Am Ruettacker 3
79379 Muellheim / DE
05 / MAERKI, Hans-Peter
Seltisbergerstrasse 75
CH-4059 Basel / CH
06 / MARTIN, Rainer, Eugen
Vogesenstrasse 47
CH-4056 Basel / CH
07 / MOHR, Peter
Benkenstrasse 26
CH-4054 Basel / CH
 [2007/48]
Representative(s)Klostermeyer-Rauber, Dörte
F. Hoffmann-La Roche AG Corporate Law Patents (CLP) Grenzacherstrasse 124
4070 Basel / CH
[2009/47]
Former [2007/48]Klostermeyer, Dörte
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
CH-4070 Basel / CH
Application number, filing date06723145.628.02.2006
[2007/48]
WO2006EP01843
Priority number, dateEP2005010181509.03.2005         Original published format: EP 05101815
[2007/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006094682
Date:14.09.2006
Language:EN
[2006/37]
Type: A1 Application with search report 
No.:EP1858901
Date:28.11.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 14.09.2006 takes the place of the publication of the European patent application.
[2007/48]
Type: B1 Patent specification 
No.:EP1858901
Date:05.11.2008
Language:EN
[2008/45]
Search report(s)International search report - published on:EP14.09.2006
ClassificationIPC:C07D513/04, C07D498/04, C07D417/12, C07D413/12, C07D277/82, C07D263/58, A61K31/4468, A61P3/10
[2007/48]
CPC:
C07D413/14 (EP,US); C07D417/12 (EP,KR,US); A61P1/04 (EP);
A61P1/14 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P37/04 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07D263/58 (EP,US); C07D277/82 (EP,US);
C07D413/12 (EP,KR,US); C07D417/14 (EP,US); C07D498/04 (KR);
C07D513/04 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/48]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:BENZOTHIAZOL-, THIAZOLOPYRIDIN-, BENZOOXAZOL- UND OXAZOLOPYRIDIN-DERIVATE ALS VERBINDUNGEN ZUR BEHANDLUNG VON DIABETES[2007/48]
English:BENZOTHIAZOLE, THIAZOLOPYRIDINE, BENZOOXAZOLE AND OXAZOLOPYRIDINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS[2007/48]
French:DERIVES DE BENZOTHIAZOLE, DE THIAZOLOPYRIDINE, DE BENZOOXAZOLE ET D'OXAZOLOPYRIDINE EN TANT QUE COMPOSES ANTIDIABETIQUES[2007/48]
Entry into regional phase09.10.2007National basic fee paid 
09.10.2007Designation fee(s) paid 
09.10.2007Examination fee paid 
Examination procedure09.10.2007Examination requested  [2007/48]
22.11.2007Amendment by applicant (claims and/or description)
04.07.2008Communication of intention to grant the patent
23.09.2008Fee for grant paid
23.09.2008Fee for publishing/printing paid
Opposition(s)06.08.2009No opposition filed within time limit [2009/42]
Fees paidRenewal fee
08.02.2008Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY05.11.2008
CZ05.11.2008
DK05.11.2008
EE05.11.2008
LT05.11.2008
LV05.11.2008
PL05.11.2008
RO05.11.2008
SI05.11.2008
SK05.11.2008
TR05.11.2008
BG05.02.2009
GR06.02.2009
LU28.02.2009
MC28.02.2009
IS05.03.2009
PT06.04.2009
[2011/43]
Former [2011/22]CZ05.11.2008
DK05.11.2008
EE05.11.2008
LT05.11.2008
LV05.11.2008
PL05.11.2008
RO05.11.2008
SI05.11.2008
SK05.11.2008
BG05.02.2009
GR06.02.2009
LU28.02.2009
MC28.02.2009
IS05.03.2009
PT06.04.2009
Former [2011/04]CZ05.11.2008
DK05.11.2008
EE05.11.2008
LT05.11.2008
LV05.11.2008
PL05.11.2008
RO05.11.2008
SI05.11.2008
SK05.11.2008
BG05.02.2009
GR06.02.2009
MC28.02.2009
IS05.03.2009
PT06.04.2009
Former [2010/03]CZ05.11.2008
DK05.11.2008
EE05.11.2008
LT05.11.2008
LV05.11.2008
PL05.11.2008
RO05.11.2008
SI05.11.2008
SK05.11.2008
BG05.02.2009
MC28.02.2009
IS05.03.2009
PT06.04.2009
Former [2009/29]LT05.11.2008
LV05.11.2008
PL05.11.2008
SI05.11.2008
IS05.03.2009
Former [2009/21]LT05.11.2008
Cited inInternational search[A]EP0184257  (JANSSEN PHARMACEUTICA NV [BE]) [A] 1-36 * compounds 94,99,129 *;
 [A]WO2004014885  (MCR RES INC [CA], et al) [A] 1-36 * examples 27b,36d,37,38 *;
 [A]  - CONTOUR-GALCERA M-O ET AL, "Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (20010312), vol. 11, no. 5, ISSN 0960-894X, pages 741 - 745, XP004230102 [A] 1-36 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0960-894X(01)00051-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.